The effect of walnut intake on factors related to prostate and vascular health in older men

Nutrition Journal

Volumn 7, Issue 1, 2008, Pages

  Spaccarotella, Kim J ^a   Kris Etherton, Penny M ^b   Stone, William L ^c   Bagshaw, Deborah M ^b   Fishell, Valerie K ^b   West, Sheila G ^b   Lawrence, Frank R ^b   Hartman, Terryl J ^b  

^a RUTGERS UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA TOCOPHEROL; PROSTATE SPECIFIC ANTIGEN; TOCOPHEROL; TRIACYLGLYCEROL; ALPHA TOCOPHEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WALNUT; BLOOD; CHEMISTRY; CROSSOVER PROCEDURE; MIDDLE AGED; PROSTATE TUMOR; RISK FACTOR; VASCULAR DISEASE;

JUGLANS;

AGED; ALPHA-TOCOPHEROL; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; GAMMA-TOCOPHEROL; HUMANS; JUGLANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TOCOPHEROLS; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 44849143707     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-7-13     Document Type: Article

References (50)

1. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. World Health Organization, 2003
2. Cancer Statistics, 1999. S Landis S Bolden P Wingo, CA Cancer J Clin 1999 49 28 41
3. Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men. K Weisman G Larijani M Goldstein M Goldberg, Pharmacotherapy 2000 20 383 386 10.1592/phco.20.5.383.35053 10772367
4. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. J Hammarsten B Högstedt, Blood Press 1999 8 29 36 10.1080/080370599438365 10412880
5. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. W Catalona D Smith D Ornstein, JAMA 1997 277 1452 1455 10.1001/jama.277.18.1452 9145717
6. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, N Engl J Med 1994 330 1029 1035 10.1056/NEJM199404143301501 8127329
7. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. J Chan M Stampfer E Giovannucci P Gann J Ma P Wilkinson C Hennekens M Pollak, Science 1998 279 563 566 10.1126/science.279.5350.563 9438850
8. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. K Helzlsouer H Huang A Alberg S Hoffman A Burke E Norkus J Morris G Comstock, J Natl Cancer Inst 2000 92 2018 2023 10.1093/jnci/92.24.2018 11121464
9. Vitamin E consumption and the risk of coronary heart disease in men. E Rimm M Stampfer A Ascherio E Giovannucci G Colditz W Willett, N Engl J Med 1993 328 1450 1456 10.1056/NEJM199305203282004 8479464
10. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. P Knekt A Reunanen R Järvinen R Seppänen M Heliövaara A Aromaa, Am J Epidemiol 1994 139 1180 1189 8209876
11. Lower ischemic heart disease incidence and mortality among vitamin supplement users. F Meyer I Bairati G Dagenais, Can J Cardiol 1996 12 930 934 9191483
12. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. D Boscoboinik A Szewczyk C Hensey A Azzi, J Biol Chem 1991 266 6188 6194 2007576
13. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. E Chatelain D Boscoboinik G Bartoli V Kagan F Gey L Packer A Azzi, Biochim Biophys Acta 1993 1176 83 89 10.1016/0167-4889(93)90181-N 7680904
14. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. K Israel B Sanders K Kline, Nutr Cancer 1995 24 161 169 8584452
15. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. G Sigounas A Anagnostou M Steiner, Nutr Cancer 1997 28 30 35 9200147
16. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. R Gysin A Azzi T Visarius, FASEB J 2002 16 1952 1954 12368234
17. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. M Liu A Wallmon C Olsson-Mortlock R Wallin T Saldeen, Am J Clin Nutr 2003 77 700 706 12600864
18. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. J Freedman J Farhat J Loscalzo JJ Keaney, Circulation 1996 94 2434 2440 8921785
19. National Nutrient Database for Standard Reference. http://www.ars.usda. gov/site_main.htm?modecode=12-35-45-00
20. Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. E Daniel, J Food Compos Anal 1989 2 338 349 10.1016/0889-1575(89) 90005-7
21. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. B Narayanan O Geoffroy M Willingham G Re D Nixon, Cancer Lett 1999 136 215 221 10.1016/S0304-3835(98) 00323-1 10355751
22. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. L Labrecque S Lamy A Chapus S Mihoubi Y Durocher B Cass M Bojanowski D Gingras R Béliveau, Carcinogenesis 2005 26 821 826 10.1093/carcin/bgi024 15661805
23. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. P Kris-Etherton S Yu-Poth J Sabaté H Ratcliffe G Zhao T Etherton, Am J Clin Nutr 1999 70 504S 511S 10479223
24. A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects. A Chisholm J Mann M Skeaff C Frampton W Sutherland A Duncan S Tiszavari, Eur J Clin Nutr 1998 52 12 16 10.1038/sj.ejcn.1600507 9481526
25. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. M Abbey M Noakes G Belling P Nestel, Am J Clin Nutr 1994 59 995 999 8172107
26. Effects of walnuts on serum lipid levels and blood pressure in normal men. J Sabaté G Fraser K Burke S Knutsen H Bennett K Lindsted, N Engl J Med 1993 328 603 607 10.1056/NEJM199303043280902 8357360
27. Postprandial changes in the plasma concentration of alpha- and gamma-tocopherol in human subjects fed a fat-rich meal supplemented with fat-soluble vitamins. M Meydani J Cohn J Macauley J McNamara J Blumberg E Schaefer, J Nutr 1989 119 1252 1258 2795239
28. The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. Y Jeanes W Hall S Ellard E Lee J Lodge, Br J Nutr 2004 92 575 579 10.1079/BJN20041249 15522126
29. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. P Kris-Etherton J Dietschy, Am J Clin Nutr 1997 65 1590S 1596S 9129499
30. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. W Harris W Connor N Alam D Illingworth, J Lipid Res 1988 29 1451 1460 3241121
31. Postprandial lipoprotein(a) is affected differently by specific individual dietary fatty acids in healthy young men. T Tholstrup S Samman, J Nutr 2004 134 2550 2555 15465746
32. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. H Roche M Gibney, Am J Clin Nutr 2000 71 232S 237S 10617977
33. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. J Bieri T Tolliver G Catignani, Am J Clin Nutr 1979 32 2143 2149 484533
34. Dose response effects of almonds on serum lipid levels in healthy men and women: a randomized feeding trial. J Sabate S Rajaram P Jambazian J Tanzman E Hadad, FASEB J 2001 15
35. Validation of a symptoms questionnaire for benign prostatic hyperplasia. J Bolognese R Kozloff S Kunitz P Grino D Patrick E Stoner, Prostate 1992 21 247 254 10.1002/pros.2990210308 1279647
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. W Friedewald R Levy D Fredrickson, Clin Chem 1972 18 499 502 4337382
37. Gamma-tocopherol as a possible marker for nutrition-related risk: results from four National Diet and Nutrition Surveys in Britain. C Bates G Mishra A Prentice, Br J Nutr 2004 92 137 150 10.1079/BJN20041156 15230997
38. Corn and sesame oils increase serum gamma-tocopherol concentrations in healthy Swedish women. M Lemcke-Norojärvi A Kamal-Eldin L Appelqvist L Dimberg M Ohrvall B Vessby, J Nutr 2001 131 1195 1201 11285325
39. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. M Ohrvall G Sundlöf B Vessby, J Intern Med 1996 239 111 117 10.1046/j.1365-2796.1996.410753000.x 8568478
40. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. M Clarke N Ward J Wu J Hodgson I Puddey K Croft, Am J Clin Nutr 2006 83 95 102 16400056
41. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. M Traber G Burton L Hughes K Ingold H Hidaka M Malloy J Kane J Hyams H Kayden, J Lipid Res 1992 33 1171 1182 1431596
42. gamma-Tocopherol biokinetics and transformation in humans. F Galli R Lee J Atkinson A Floridi F Kelly, Free Radic Res 2003 37 1225 1233 10.1080/10715760310001604125 14703735
43. Nut consumption and body weight. J Sabaté Am J Clin Nutr 2003 78 647S 650S 12936960
44. Does regular walnut consumption lead to weight gain? J Sabaté Z Cordero-Macintyre G Siapco S Torabian E Haddad, Br J Nutr 2005 94 859 864 10.1079/BJN20051567 16277792
45. HDL cholesterol: trends in two southeastern New England communities, 1981-1993. C Derby H Feldman L Bausserman D Parker K Gans R Carleton, Ann Epidemiol 1998 8 84 91 10.1016/S1047-2797(97)00130-0 9491932
46. Effects of walnut consumption as part of a low-fat, low-cholesterol diet on serum cardiovascular risk factors. J Morgan K Horton D Reese C Carey K Walker D Capuzzi, Int J Vitam Nutr Res 2002 72 341 347 10.1024/0300-9831.72.5.341 12463111
47. Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. M Dietrich M Traber P Jacques C Cross Y Hu G Block, J Am Coll Nutr 2006 25 292 299 16943450
48. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. I Brower M Katan P Zock, J Nutr 2004 134 919 922 15051847
49. alpha-linolenic acid, coronary heart disease, and prostate cancer. M de Lorgeril P Salen, J Nutr 2004 134 3385 3386 author reply 15570041
50. A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). D Koralek U Peters G Andriole D Reding V Kirsh A Subar A Schatzkin R Hayes M Leitzmann, Cancer Causes Control 2006 17 783 791 10.1007/s10552-006-0014-x 16783606